Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
remimazolam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | ligand |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | ligand |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | ligand |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | ligand |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | ligand |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | ligand |
remimazolam | gaba(a) receptor gamma-3 | NA | Successful target | TTD , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | approved | unknown |
remimazolam | gaba(a) receptor benzodiazepine binding site | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | approved,investigational | ligand |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
remimazolam | gaba(a) receptor | small molecule | NA | drugbank | Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | positive allosteric modulator |
click here to return to the previous page |